Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL294411 | 1.00 | NAAA (0.55) | NAAACA2EPHX1TSHRZDHHC7 | |
| SCHEMBL20535742 | 1.00 | NAAA (0.55) | NAAACA2EPHX1TSHRZDHHC7 | |
| SCHEMBL5179238 | 1.00 | NAAA (0.55) | NAAACA2EPHX1TSHRZDHHC7 | |
| SCHEMBL20767416 | 1.00 | NAAA (0.55) | NAAACA2EPHX1TSHRZDHHC7 | |
| SCHEMBL20512287 | 1.00 | NAAA (0.55) | NAAACA2EPHX1TSHRZDHHC7 | |
| SCHEMBL296649 | 1.00 | NAAA (0.55) | NAAACA2EPHX1TSHRZDHHC7 | |
| SCHEMBL730516 | 1.00 | NAAA (0.55) | NAAACA2EPHX1TSHRZDHHC7 | |
| SCHEMBL698630 | 1.00 | NAAA (0.55) | NAAACA2EPHX1TSHRZDHHC7 | |
| SCHEMBL21247597 | 1.00 | NAAA (0.55) | NAAACA2EPHX1TSHRZDHHC7 | |
| SCHEMBL9770100 | 1.00 | NAAA (0.55) | NAAACA2EPHX1TSHRZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115433376-A | Preparation method of long-acting disinfection and sterilization fabric or fiber | 孙国明 | 2022-12-06 | — | — | CN | claimed |
| US-11944092-B2 | Compositions for controlling phytoplankton contamination | BLUEGREEN WATER TECHNOLOGIES LTD. (IL) | 2024-04-02 | — | — | US | disclosed |
| US-20230414512-A1 | Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same | LABORATORY SKIN CARE, INC. | 2023-12-28 | — | — | US | disclosed |
| CN-116887798-A | Anti-pollution agent | OMYA国际股份公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-111655342-B | Surface-reacted calcium carbonate as skin appearance modifier | 欧米亚国际集团 | 2023-09-12 | — | — | CN | disclosed |
| CN-116685240-A | Keratin fiber modeling tool and related tool kit and method | 欧莱雅 | 2023-09-01 | — | — | CN | disclosed |
| EP-4218718-A2 | DERMAL DELIVERY COMPOSITIONS COMPRISING ACTIVE AGENT-CALCIUM PHOSPHATE PARTICLE COMPLEXES AND METHODS OF USING THE SAME | Laboratory Skin Care, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| CN-110366408-B | Cosmetic composition comprising one or more polar oils, a C2-C6 aliphatic monohydric and polyhydric alcohol, at least one hydrophilic active agent, and comprising less than 7% by weight of water | 莱雅公司 | 2023-05-02 | — | — | CN | disclosed |
| EP-2427178-B1 | DERMAL DELIVERY COMPOSITIONS COMPRISING ACTIVE AGENT-CALCIUM PHOSPHATE PARTICLE COMPLEXES AND METHODS OF USING THE SAME | LABORATORY SKIN CARE INC (US) | 2023-01-04 | — | — | EP | disclosed |
| CN-108697594-B | Composition comprising photonic particles, at least one absorber and at least one surfactant | 欧莱雅 | 2023-01-03 | — | — | CN | disclosed |
| US-20050271699-A1 | Biodegradable composition with prolonged release of the biological active compound and preparation thereof | PLIVA-LACHEMA A.S. (CZ) | 2005-12-08 | — | — | US | disclosed |
| US-6964775-B1 | Decorative cosmetic preparations | BIOTEC ASA (NO) | 2005-11-15 | — | — | US | disclosed |
| EP-1536768-A1 | BIODEGRADABLE COMPOSITION WITH PROLONGED RELEASE OF THE BIOLOGICAL ACTIVE COMPOUND AND PREPARATION THEREOF | Pliva-Lachema A.S. (CZ) | 2005-06-08 | — | — | EP | disclosed |
| WO-2004017937-A1 | BIODEGRADABLE COMPOSITION WITH PROLONGED RELEASE OF THE BIOLOGICAL ACTIVE COMPOUND AND PREPARATION THEREOF | PLIVA-LACHEMA A.S. (CZ) | 2004-03-04 | — | — | WO | disclosed |
| US-20030103915-A1 | Combinations of sunscreens | 3V SIGMA S.P.A. (IT) | 2003-06-05 | — | — | US | disclosed |
| EP-1300137-A2 | Combinations of sunscreens | 3V SIGMA S.p.A (IT) | 2003-04-09 | — | — | EP | disclosed |
| CN-1406577-A | Cosmetic W/O emulsion and agents for skin containing amino substituted hydroxy diphenyl ketone | BASF AG (DE) | 2003-04-02 | — | — | CN | disclosed |
| US-6488946-B1 | SELF-EMULSIFIABLE; DEGREE OF POLYMERISATION OF BETWEEN 1 AND 3; COSMETICS | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES-S.E.P.P.I.C. (FR) | 2002-12-03 | — | — | US | disclosed |
| EP-0927019-A1 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MedLogic Global Corporation (US) | 1999-07-07 | — | — | EP | disclosed |
| WO-1998048768-A1 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MEDLOGIC GLOBAL CORPORATION (US) | 1998-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030103915-A1 | Combinations of sunscreens | ERCC4, ERCC1, ERCC5 | NAAA 3209/4885CA2 3860/4885EPHX1 1434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.